Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

The heart in Friedreich ataxia: definition of cardiomyopathy, disease severity, and correlation with neurological symptoms.

Weidemann F, Rummey C, Bijnens B, Störk S, Jasaityte R, Dhooge J, Baltabaeva A, Sutherland G, Schulz JB, Meier T; Mitochondrial Protection with Idebenone in Cardiac or Neurological Outcome (MICONOS) study group.

Circulation. 2012 Apr 3;125(13):1626-34. doi: 10.1161/CIRCULATIONAHA.111.059477. Epub 2012 Feb 29.

2.

Cardiomyopathy in Friedreich's ataxia-assessment by cardiac MRI.

Meyer C, Schmid G, Görlitz S, Ernst M, Wilkens C, Wilhelms I, Kraus PH, Bauer P, Tomiuk J, Przuntek H, Mügge A, Schöls L.

Mov Disord. 2007 Aug 15;22(11):1615-22.

PMID:
17546670
3.

Letter by Peverill regarding article, "The heart in Friedreich ataxia: definition of cardiomyopathy, disease severity, and correlation with neurological symptoms".

Peverill RE.

Circulation. 2012 Oct 23;126(17):e272. doi: 10.1161/CIRCULATIONAHA.112.115287. No abstract available.

4.

The longitudinal course of cardiomyopathy in Friedreich's ataxia during childhood.

Kipps A, Alexander M, Colan SD, Gauvreau K, Smoot L, Crawford L, Darras BT, Blume ED.

Pediatr Cardiol. 2009 Apr;30(3):306-10. doi: 10.1007/s00246-008-9305-1. Epub 2008 Aug 21.

PMID:
18716706
5.

The cardiomyopathy in Friedreich's ataxia - New biomarker for staging cardiac involvement.

Weidemann F, Liu D, Hu K, Florescu C, Niemann M, Herrmann S, Kramer B, Klebe S, Doppler K, Üçeyler N, Ritter CO, Ertl G, Störk S.

Int J Cardiol. 2015 Sep 1;194:50-7. doi: 10.1016/j.ijcard.2015.05.074. Epub 2015 May 15.

6.

Spectrum of cardiac involvement in Friedreich's ataxia: clinical, electrocardiographic and echocardiographic observations.

Alboliras ET, Shub C, Gomez MR, Edwards WD, Hagler DJ, Reeder GS, Seward JB, Tajik AJ.

Am J Cardiol. 1986 Sep 1;58(6):518-24.

PMID:
2944367
7.

The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease.

Weidemann F, Breunig F, Beer M, Sandstede J, Störk S, Voelker W, Ertl G, Knoll A, Wanner C, Strotmann JM.

Eur Heart J. 2005 Jun;26(12):1221-7. Epub 2005 Feb 23.

PMID:
15728649
8.

Neurological, cardiological, and oculomotor progression in 104 patients with Friedreich ataxia during long-term follow-up.

Ribaï P, Pousset F, Tanguy ML, Rivaud-Pechoux S, Le Ber I, Gasparini F, Charles P, Béraud AS, Schmitt M, Koenig M, Mallet A, Brice A, Dürr A.

Arch Neurol. 2007 Apr;64(4):558-64.

PMID:
17420319
9.

Left ventricular function in Friedreich's ataxia. An echocardiographic study.

Sutton MG, Olukotun AY, Tajik AJ, Lovett JL, Giuliani ER.

Br Heart J. 1980 Sep;44(3):309-16.

10.

Cardiac function, perfusion, and morbidity in irradiated long-term survivors of Hodgkin's disease.

Constine LS, Schwartz RG, Savage DE, King V, Muhs A.

Int J Radiat Oncol Biol Phys. 1997 Nov 1;39(4):897-906.

PMID:
9369139
11.

Morphologic and functional characteristics of the heart in Friedreich's ataxia.

Unverferth DV, Schmidt WR 2nd, Baker PB, Wooley CF.

Am J Med. 1987 Jan;82(1):5-10.

PMID:
3799693
12.

[Reliability and limitation of various diagnostic methods including nuclear medicine in myocardial disease (author's transl)].

Tokuyasu Y, Kusakabe K, Yamazaki T, Tazaki E, Sekiguchi M, Hiroe M, Morimoto S, Fujioka T, Nakamura K, Hirosawa K.

J Cardiogr. 1981 Dec;11(4):1113-25. Japanese.

PMID:
7201492
13.

Marked variation in the cardiomyopathy associated with Friedreich's ataxia.

Dutka DP, Donnelly JE, Nihoyannopoulos P, Oakley CM, Nunez DJ.

Heart. 1999 Feb;81(2):141-7.

14.

[Clinical significance of magnetic resonance and echocardiographic correlations in the evaluation of hypertrophic cardiomyopathy].

Fattori R, Rapezzi C, Castriota F, Magnani G, Bertaccini P, Galiè N, Magnani B, Gavelli G.

Radiol Med. 1994 Jul-Aug;88(1-2):36-43. Italian.

PMID:
8066253
15.

Measuring Friedreich ataxia: complementary features of examination and performance measures.

Lynch DR, Farmer JM, Tsou AY, Perlman S, Subramony SH, Gomez CM, Ashizawa T, Wilmot GR, Wilson RB, Balcer LJ.

Neurology. 2006 Jun 13;66(11):1711-6.

PMID:
16769945
16.

Hypertrophic cardiomyopathy in Friedreich's ataxia: symmetric or asymmetric?

Pasternac A, Król R, Petitclerc R, Harvey C, Andermann E, Barbeau A.

Can J Neurol Sci. 1980 Nov;7(4):379-82.

PMID:
7194134
17.

Impaired myocardial perfusion reserve and fibrosis in Friedreich ataxia: a mitochondrial cardiomyopathy with metabolic syndrome.

Raman SV, Phatak K, Hoyle JC, Pennell ML, McCarthy B, Tran T, Prior TW, Olesik JW, Lutton A, Rankin C, Kissel JT, Al-Dahhak R.

Eur Heart J. 2011 Mar;32(5):561-7. doi: 10.1093/eurheartj/ehq443. Epub 2010 Dec 14.

18.

Echocardiographic evaluation of verapamil in Friedreich's ataxia.

Casazza F, Ferrari F, Finocchiaro G, Hartwig J, Piccone U, Tramarin R, Morpurgo M.

Br Heart J. 1986 Apr;55(4):400-4.

19.

The GAA repeat expansion in intron 1 of the frataxin gene is related to the severity of cardiac manifestation in patients with Friedreich's ataxia.

Bit-Avragim N, Perrot A, Schöls L, Hardt C, Kreuz FR, Zühlke C, Bubel S, Laccone F, Vogel HP, Dietz R, Osterziel KJ.

J Mol Med (Berl). 2001;78(11):626-32.

PMID:
11269509
20.

[Cardiac involvement in Friedreich's heredo-ataxia].

Bertoni PD, Canziani R, Cozzi G, Arancio F, Marforio S.

G Ital Cardiol. 1986 Jan;16(1):22-9. Italian.

PMID:
2940141

Supplemental Content

Support Center